Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
US Army
Merck
Argus Health
Healthtrust
Federal Trade Commission
Teva
UBS
Queensland Health
Chinese Patent Office

Generated: August 21, 2017

DrugPatentWatch Database Preview

FINACEA Drug Profile

« Back to Dashboard

What is the patent landscape for Finacea, and what generic Finacea alternatives are available?

Finacea is a drug marketed by Bayer Hlthcare and is included in two NDAs. There are eight patents protecting this drug and one Paragraph IV challenge.

This drug has one hundred and eighty-eight patent family members in thirty-one countries.

The generic ingredient in FINACEA is azelaic acid. There are eight drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the azelaic acid profile page.

Summary for Tradename: FINACEA

Patents:8
Applicants:1
NDAs:2
Suppliers / Packagers: see list4
Bulk Api Vendors: see list71
Clinical Trials: see list8
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FINACEA at DailyMed

Pharmacology for Tradename: FINACEA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare
FINACEA
azelaic acid
GEL;TOPICAL021470-001Dec 24, 2002RXYesYes► Subscribe► Subscribe ► Subscribe
Bayer Hlthcare
FINACEA
azelaic acid
AEROSOL, FOAM;TOPICAL207071-001Jul 29, 2015RXYesYes► Subscribe► Subscribe ► Subscribe
Bayer Hlthcare
FINACEA
azelaic acid
AEROSOL, FOAM;TOPICAL207071-001Jul 29, 2015RXYesYes► Subscribe► SubscribeY ► Subscribe
Bayer Hlthcare
FINACEA
azelaic acid
AEROSOL, FOAM;TOPICAL207071-001Jul 29, 2015RXYesYes► Subscribe► Subscribe ► Subscribe
Bayer Hlthcare
FINACEA
azelaic acid
AEROSOL, FOAM;TOPICAL207071-001Jul 29, 2015RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: FINACEA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Hlthcare
FINACEA
azelaic acid
GEL;TOPICAL021470-001Dec 24, 2002► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: FINACEA

Drugname Dosage Strength RLD Submissiondate
azelaic acidGel15%Finacea7/27/2012

Non-Orange Book Patents for Tradename: FINACEA

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,622,947Foamable composition combining a polar solvent and a hydrophobic carrier► Subscribe
8,119,150Non-flammable insecticide composition and uses thereof► Subscribe
8,518,378Oleaginous pharmaceutical and cosmetic foam► Subscribe
7,820,145Oleaginous pharmaceutical and cosmetic foam► Subscribe
8,114,385Oleaginous pharmaceutical and cosmetic foam► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: FINACEA

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2007102052► Subscribe
Canada2611147► Subscribe
Israel173092► Subscribe
Germany59802473► Subscribe
World Intellectual Property Organization (WIPO)2008038140► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Medtronic
Healthtrust
Boehringer Ingelheim
Covington
US Department of Justice
Johnson and Johnson
Merck
Farmers Insurance
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot